Renishaw creates new business division for radio frequency products
August 1, 2011
Renishaw plc, the world leading engineering and healthcare technologies company, has announced the creation of a new radio frequency (RF) products division, following its recent acquisition of the remaining shares in PulseTeq Ltd, in which it had first invested in 2005. From 1st July 2011, the business operations of PulseTeq Ltd have been fully integrated [...]
August 1, 2011
San Dimas, CA -- CRAIC Technologies has developed the new CRAIC Apollo™ Raman microspectrometer . This unit is designed to be used either in a standalone configuration or it can be added to a CRAIC Technologies UV-visible-NIR microspectrophotometer to enhance its capabilities with Raman microspectroscopy. When added to a unit such as the 20/20 PV™ [...]
August 1, 2011
HOUSTON - In an effort to meet the growing demand of its integrated analytical solutions, Siemens Industry's Process Instrumentation and Analytics, based in Houston, announces a strategic partnership with S&B Plant Services Ltd. to support companies in the oil & gas, energy, water and wastewater and minerals industries. Siemens Process Instrumentation & Analytics, part of [...]
Affymetrix To Release Axiom Array Plates Optimized for NIH-funded Genotyping Study of 100,000 People
August 1, 2011
SANTA CLARA, Calif. -- Affymetrix, Inc. today announced plans to commercialize four Axiom(R) population-optimized arrays used to analyze 100,000 samples collected from volunteers in one of the nation's largest and most diverse genomics projects funded by the National Institutes of Health (NIH). Each Axiom genotyping array is optimized for the major populations, including those from [...]
August 1, 2011
Framingham, MA - Pharmaceutical scientists typically face a meager five percent success rate for anti-cancer drugs in clinical trials. To help improve this success rate, Japanese scientists, led by Dr. Tetsuya Terasaki, one of the top pharmaceutical scientists focused on drug transporters, have developed a new approach designed to overcome complexities of developing new, more [...]
August 1, 2011
WOBURN, Mass.--PathoGenetiX Inc., today announced that the Company has received $4.0 million in the first closing of its Series B financing. The Company has received $9.5 million in commitments from investors for the Series B. The funds will be used to complete development of PathoGenetiX’s first commercial systems for identifying pathogens in complex biological samples [...]
LECO Corporation Opens New Separation Science Facility in Europe
August 1, 2011
St. Joseph, Mich. — The LECO European Life Sciences and Chemical Analysis Centre recently opened in Mönchengladbach, Germany. This new 330 square-meter (3,550 square-foot) facility is dedicated to separation science sales and applications—providing support, method development, sample analysis, and instrument demonstrations to new and current customers throughout Europe. Grand-opening festivities included a ribbon-cutting and tours [...]
August 1, 2011
LEXINGTON, Mass. -- RainDance Technologies, Inc., the leading provider of microdroplet-based solutions for single molecule and single cell analysis, today announced the publication of two significant studies that further validate the use of the company’s MethylSeq™ Solution to power large-scale epigenetic research projects. Published separately in Genome Research and PLoS ONE, these two studies from [...]
LabGard ES NU-629 Animal Biological Safety Cabinet Updates
August 1, 2011
PLYMOUTH, Minn. -- NuAire is universally recognized as the leader in providing laboratory professionals with reliable products for the most demanding environments. NuAire is pleased to announce product updates to the LabGard ES model NU-629 Animal Handling Class II, Type A2 Biological Safety Cabinet. The LabGard ES NU-629 provides personnel, product, and environmental protection for [...]
August 1, 2011
MILFORD, Mass. - SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that its Board of Directors has initiated a process to explore and evaluate potential strategic alternatives for the Company to enhance shareholder value, which [...]

